These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 36660710)

  • 41. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma.
    Zhu W; Ye Z; Chen L; Liang H; Cai Q
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154
    [TBL] [Abstract][Full Text] [Related]  

  • 42. LINC00638/hsa-miR-29b-3p axis-mediated high expression of CDCA4 correlates with tumor immune infiltration and hepatocellular carcinoma progression.
    Wang B; Chen L; Li Q; Zhou J; Jin W
    Transl Cancer Res; 2023 May; 12(5):1290-1306. PubMed ID: 37304553
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma.
    Xu Z; Peng B; Liang Q; Chen X; Cai Y; Zeng S; Gao K; Wang X; Yi Q; Gong Z; Yan Y
    Front Immunol; 2021; 12():719175. PubMed ID: 34603293
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Construction of a cancer-associated fibroblasts-related long non-coding RNA signature to predict prognosis and immune landscape in pancreatic adenocarcinoma.
    Ye Y; Zhao Q; Wu Y; Wang G; Huang Y; Sun W; Zhang M
    Front Genet; 2022; 13():989719. PubMed ID: 36212154
    [No Abstract]   [Full Text] [Related]  

  • 45. Development and validation of multi-omic prognostic signature of anoikis-related genes in liver hepatocellular carcinoma.
    Ding D; Wang D; Qin Y
    Medicine (Baltimore); 2023 Nov; 102(46):e36190. PubMed ID: 37986299
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical significance and immune landscape of cuproptosis-related lncRNAs in kidney renal clear cell carcinoma: a bioinformatical analysis.
    Li D; Wu X; Song W; Cheng C; Hao L; Zhang W
    Ann Transl Med; 2022 Nov; 10(22):1235. PubMed ID: 36544675
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunological Value of Prognostic Signature Based on Cancer Stem Cell Characteristics in Hepatocellular Carcinoma.
    Xu Q; Xu H; Chen S; Huang W
    Front Cell Dev Biol; 2021; 9():710207. PubMed ID: 34409040
    [No Abstract]   [Full Text] [Related]  

  • 48. Assessment of prognostic role of a novel 7-lncRNA signature in HCC patients.
    Qu J; Tao D; Huang W; Lu L; Fan J; Zhang S; Huang F
    Heliyon; 2023 Aug; 9(8):e18493. PubMed ID: 37520979
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Construction of a Prognostic Immune-Related LncRNA Risk Model for Lung Adenocarcinoma.
    Li Y; Shen R; Wang A; Zhao J; Zhou J; Zhang W; Zhang R; Zhu J; Liu Z; Huang JA
    Front Cell Dev Biol; 2021; 9():648806. PubMed ID: 33869203
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of hepatocellular carcinoma-related subtypes and development of a prognostic model: a study based on ferritinophagy-related genes.
    Wang G; Li J; Zhu L; Zhou Z; Ma Z; Zhang H; Yang Y; Niu Q; Wang X
    Discov Oncol; 2023 Aug; 14(1):147. PubMed ID: 37555866
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Disulfideptosis-associated lncRNAs reveal features of prognostic, immune escape, tumor mutation, and tumor malignant progression in renal clear cell carcinoma.
    Li X; Deng X; Liu T; Zhang W; Tao J
    Aging (Albany NY); 2024 Feb; 16(4):3280-3301. PubMed ID: 38334964
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic model and immunotherapy prediction based on molecular chaperone-related lncRNAs in lung adenocarcinoma.
    Xu Y; Tao T; Li S; Tan S; Liu H; Zhu X
    Front Genet; 2022; 13():975905. PubMed ID: 36313456
    [No Abstract]   [Full Text] [Related]  

  • 53. Exploring Prognostic Signatures of Hepatocellular Carcinoma and the Potential Implications in Tumor Immune Microenvironment.
    Chen H; Jiang Z; Yang B; Yan G; Wang X; Zang S
    Comb Chem High Throughput Screen; 2022; 25(6):998-1004. PubMed ID: 33687891
    [TBL] [Abstract][Full Text] [Related]  

  • 54. System analysis based on the cuproptosis-related genes identifies LIPT1 as a novel therapy target for liver hepatocellular carcinoma.
    Yan C; Niu Y; Ma L; Tian L; Ma J
    J Transl Med; 2022 Oct; 20(1):452. PubMed ID: 36195876
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Interferon Gamma-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Colon Adenocarcinoma.
    Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Xie Y
    Front Oncol; 2022; 12():876660. PubMed ID: 35747790
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development and validation of a novel endoplasmic reticulum stress-related lncRNA prognostic signature and candidate drugs in breast cancer.
    Cai J; Ji Z; Wu J; Chen L; Zheng D; Chen Y; Zhang X; Xie W; Huang J; Chen M; Lin R; Lin W; Chen Y; Li Z
    Front Genet; 2022; 13():949314. PubMed ID: 36092873
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification and validation of a seven m6A-related lncRNAs signature predicting prognosis of ovarian cancer.
    Song Y; Qu H
    BMC Cancer; 2022 Jun; 22(1):633. PubMed ID: 35676619
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of a Pyroptosis-Related Prognostic Signature Combined With Experiments in Hepatocellular Carcinoma.
    Li H; Li T; Zhang X
    Front Mol Biosci; 2022; 9():822503. PubMed ID: 35309514
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification and Validation of Ubiquitin-Specific Proteases as a Novel Prognostic Signature for Hepatocellular Carcinoma.
    Ni W; Bian S; Zhu M; Song Q; Zhang J; Xiao M; Zheng W
    Front Oncol; 2021; 11():629327. PubMed ID: 33718205
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.